Published

The Neuroimaging Documentation of Psychedelic Drugs’ Effect on the Brain: dmt, lsd, Psilocybin, and Ibogaine as Examples: A Mini Review

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Brain and Neurological Disorders
Date: 2022-06-19
Source: Crossref
DOI: 10.31579/2692-9422/027
PubMed: Unavailable

Authors

Wahab Alahmari Abdul

Watch author

Derived topics and classifications

psilocybin Brain Imaging Aging Review Article Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

The Neuroimaging Documentation of Psychedelic Drugs’ Effect on the Brain: dmt, lsd, Psilocybin, and Ibogaine as Examples: A Mini Review2022-06-19

Related papers

Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health NurseSaudi Journal of Medicine and Public Health · 2024-12-30 Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brainScientific Reports · 2026-02-13 Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19 BIOLOGICAL ACTIVITY OF PSILOCYBIN EXTRACTS FROM THE FRUITING BODIES OF PSILOCYBE CUBENSIS ANTIOXIDANT AND ANTIMICROBIAL POTENTIALJournal of Microbiology Biotechnology and Food Sciences · 2025-03-12 Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathwaysAgeing Research Reviews · 2024-01-31 A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive EmergencyJournal of the American Society of Nephrology · 2022-10-31